Applied Biosciences Corp.
APPB · OTC
12/31/2019 | 9/30/2019 | 6/30/2019 | 3/31/2019 | |
|---|---|---|---|---|
| Market Cap | $54,597 | $103,821 | $110,447 | $188,677 |
| - Cash | $21 | $73 | $38 | $47 |
| + Debt | $915 | $491 | $360 | $25 |
| Enterprise Value | $55,490 | $104,239 | $110,769 | $188,655 |
| Revenue | $170 | $244 | $211 | $235 |
| % Growth | -30.6% | 15.5% | -9.8% | – |
| Gross Profit | $118 | $146 | $112 | $153 |
| % Margin | 69.7% | 59.7% | 52.8% | 65% |
| EBITDA | -$1,274 | -$777 | -$442 | -$158 |
| % Margin | -751.5% | -318% | -209% | -67.5% |
| Net Income | -$1,353 | -$778 | -$424 | -$232 |
| % Margin | -798.1% | -318.4% | -200.5% | -98.8% |
| EPS Diluted | -0.099 | -0.058 | -0.031 | -0.016 |
| % Growth | -71.6% | -88.3% | -88.3% | – |
| Operating Cash Flow | -$52 | -$367 | -$399 | -$116 |
| Capital Expenditures | $0 | $0 | $0 | -$2 |
| Free Cash Flow | -$52 | -$367 | -$399 | -$118 |